Supplemental Tables 1-3 from A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients

Autor: Patrick Y. Wen, Keith L. Ligon, Tracy T. Batchelor, Rakesh K. Jain, Katrina H. Smith, Mary Gerard, Christine S. McCluskey, Brian M. Alexander, Stephanie E. Weiss, Rameen Beroukhim, Andrew D. Norden, Jan Drappatz, Shakti Ramkissoon, Jason T. Huse, Marek Ancukiewicz, Alona Muzikansky, Benjamin W. Purow, Tom Mikkelsen, Eric T. Wong, Andrew B. Lassman, David Schiff, Dan G. Duda, Thomas J. Kaley, Eudocia Q. Lee
Rok vydání: 2023
Popis: Supplemental Tables 1-3. Supplementary Table 1: Correlations in the vandetanib/RT/TMZ arm between best radiographic responses with pre-treatment and on-treatment changes in blood biomarkers. Supplementary Table 2: Correlations in the vandetanib/RT/TMZ arm between overall survival with pre-treatment and on-treatment changes in blood biomarkers. Supplementary Table 3: Comparison of PFS or OS by log-rank p-value based on tissue biomarker analysis
Databáze: OpenAIRE